Aphasia Clinical Trial - Theory-Driven Treatment of Language & Cognitive

Status Enrolling by invitation

Clinical Trial Summary

The aim of this research is to translate a theory of the cognitive relationship between verbal short--term memory (STM) and word processing impairments in aphasia to treatment approaches for language impairment in aphasia. It has been proposed that the co-occurrence of these impairments is due to a disruption of cognitive processes that support both abilities: maintenance of activated semantic and phonological representations of words, hereafter the 'activation--maintenance hypothesis'. This hypothesis will be tested in the context of a treatment approach that aims to improve word processing and verbal STM abilities. The grant supporting this work has ended. therefore, participants are entered into the study by invitation only.

Clinical Trial Description

Based on research of word processing and verbal STM impairments in aphasia, it has been proposed that the co-occurrence of these impairments is due to a disruption of cognitive processes that support both abilities: maintenance of activated semantic and phonological representations of words, hereafter the 'activation--maintenance hypothesis'. This hypothesis will be tested in the context of a treatment approach that aims to improve word processing and verbal STM abilities. Recently, the importance of treatment research has been emphasized as a critical testing ground for theories of language processing. Although it has been demonstrated that associations between impairments of word processing and reduced verbal STM capacity support the 'activation-maintenance hypothesis', direct treatments to improve the ability to maintain activation of word representations will serve as a stronger test of this hypothesis. First, empirical support will be established for the hypothesis that impairment to short-term maintenance of activated semantic and phonological representations of words impairs language and verbal STM abilities in aphasia and that direct treatment of this deficit will improve both abilities (Specific Aim 1). Second, the effects of this treatment will be compared under two administration conditions, high and low intensity (Specific aim 2). Finally, the neural regions associated with semantic STM and phonological STM will be investigated using voxel--based lesion--symptom mapping (Bates et al., 2003) (Specific Aim 3). This research represents a unique attempt to apply more recent processing theories of aphasia to treatment of the disorder.The outcomes will have important implications for aphasia rehabilitation research. ;

Study Design

Related Conditions & MeSH terms

Aphasia

Clinical Trial Details

NCT number	NCT02664506
Study type	Interventional
Source	Temple University
Contact
Status	Enrolling by invitation
Phase	N/A
Start date	March 2014
Completion date	November 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03622411` - Tablet-based Aphasia Therapy in the Chronic Phase	N/A
Recruiting	`NCT03605381` - MORbidity PRevalence Estimate In StrokE
Recruiting	`NCT03929432` - Treatment Outcomes With tDCS in Post-Stroke Aphasia	N/A
Completed	`NCT03662295` - Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention
Completed	`NCT03679637` - Tablet-based Aphasia Therapy in the Acute Phase After Stroke	N/A
Completed	`NCT03228264` - A Trial Investigating Telerehabilitation as an add-on to Face-to-face Speech and Language Therapy in Post-stroke Aphasia.	N/A
Completed	`NCT03550092` - Analysis of Brain Activity to Uncover Brain-behavior Relationships Related to Therapy Outcomes in Aphasia	N/A
Suspended	`NCT04290988` - Circuitry Assessment and Reinforcement Training Effects on Recovery	N/A
Recruiting	`NCT05969548` - pBFS-guided cTBS at Different Doses for Aphasia After Stroke	N/A
Recruiting	`NCT04138940` - Modulating Intensity and Dosage of Aphasia Scripts	N/A
Terminated	`NCT02249819` - Evaluating Anodal tDCS Preceding Aphasia Therapy	Phase 1/Phase 2
Completed	`NCT01654029` - Patient Centred Communication Intervention	N/A
Completed	`NCT00843427` - fMRI of Language Recovery Following Stroke in Adults	N/A
Active, not recruiting	`NCT00227461` - Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.	Phase 1
Completed	`NCT03773419` - Improving Electronic Written Communication in Aphasia	N/A
Not yet recruiting	`NCT04142866` - Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia	N/A
Suspended	`NCT04048668` - tDCS to Treat Subacute Aphasia	N/A
Recruiting	`NCT04081207` - Using Augmentative & Alternative Communication to Promote Language Recovery for People With Post-Stroke Aphasia	N/A
Completed	`NCT02226796` - Transcranial Direct Stimulation (tDCS) and Behavioral Intervention in Aphasia	N/A
Completed	`NCT01163461` - Phonomotor Treatment of Word Retrieval Deficits in Individuals With Aphasia	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Theory-Driven Treatment of Language and Cognitive Processes in Aphasia

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms